Effectiveness of the Denver Developmental Screening Test with Biologically Vulnerable Infants

Sciarillo, William G.; Brown, Mary; Robinson, Nancy M.; Bennett, Forrest C.; Sells, Clifford J.

doi:10.1097/00004703-198604000-00002

Cited by 23 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CAT/CLAMS seems to fit well for the first 36 months of life. Based on studies comparing CAT/CLAMS with Bayley Scales of Infant Development (BSID), both have good correlation, as mentioned in the literature 4, 12,15. The DDST has low sensitivity [17][18][19][20][21] but in this study it achieved a good correlation with CAT/CLAMS; probably it was more accurate in our cases because it was assessed by the same Pediatric Neurologist. Our results are in agreement with Greer S et al 22 who showed that a child with an abnormal DDST is likely to have a poor school outcome.…”

Section: Discussionmentioning

confidence: 86%

Developmental milestones of vertically HIV infected and seroreverters children: follow up of 83 children

Bruck

Tahan

Cruz

et al. 2001

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

The aim of the study was to detect neurological abnormalities in human immunodeficiency virus (HIV) infected children. This was achieved by a prospective evaluation, from November/1995 to April/2000, of 43 HIV infected children (group I) and 40 HIV seroreverters children (group II) through neurological exam and neurodevelopmental tests: Denver Developmental Screening Test (DDST) and Clinical Adaptive Test / Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS). A control group (III), of 67 children, were evaluated by CAT/CLAMS. Hyperactivity, irritability and hypotonia were the findings on neurological examination, without statistical differences between group I and II. On CAT/CLAMS, the group I developmental quotient (DQ) was significantly lower than the other groups. The same occurred in DDST, with group I presenting significantly more failures than group II. Nineteen HIV children of group I had brain computed tomographic scan, with abnormalities in three of them (basal ganglia calcification, white matter hypodensity and asymmetry of lateral ventricles). We conclude that in HIV infected children a neurodevelopment delay occur early in the disease, and it can be detected by screening tests.

show abstract

Section: Discussionmentioning

confidence: 86%

Developmental milestones of vertically HIV infected and seroreverters children: follow up of 83 children

Bruck

Tahan

Cruz

et al. 2001

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

show abstract

“…More recently, it was found that the CAT/CLAMS test is Neurodevelopment HIV Children easy to apply and has both sensibility and specificity for subjects under three years of age [19]. The Denver I test, or DDST, can be used to screen for qualitative alterations in neurodevelopment of at-risk children and has the advantage that it can be applied by general pediatricians [15,18]. Because of the reduced sensibility of the Denver I test for language development, a more complete test was developed, Denver II [16].…”

Section: Discussionmentioning

confidence: 99%

Neurological profile and neurodevelopment of 88 children infected with HIV and 84 seroreverter children followed from 1995 to 2002

Tahan¹,

Bruck²,

Burger³

et al. 2006

Braz J Infect Dis

View full text Add to dashboard Cite

This study evaluated the degree of neurological compromise in HIV-infected children accompanied by the outpatient clinic of infectious diseases and pediatric neurology of the Clinical Hospital of the Federal University of Paraná (UFPR) starting in 1995. Long-term progressive prospective and cross sectional study of 88 children infected by HIV and 84 seroreverter children, using data from general neurological examinations, neuroimaging procedures (brain CT scan) and neurodevelopmental tests (CAT/CLAMS and DENVER I and II). Neurological and neurodevelopmental alterations were found in 82% of the HIV-infected patients and in 36% of the HIV-seroreverter group (P <0.01). In the CAT/ CLAMS test, the development quotient (DQ) of the HIV-infected group was significantly lower than that of the HIV-seroreverter group. CAT/CLAMS scores lower than 70 (mental deficiency) were found in 31% of the HIV-infected patients during the first year of life and in only 1% of the patients of the HIV-seroreverter group, demonstrating the validity of this screening test for precocious detection of alterations in the neurodevelopment of infected patients. The same occurred with the Denver I and II tests, as the HIV-infected group failed more frequently than the HIV-seroreverter group. Nine HIVinfected children presented altered brain CT scans; calcification of basal ganglia was the main finding (five cases). Encephalopathy due to HIV causes early arrest of neurodevelopment, which can be detected with screening tests during the first year of life.

show abstract

“…These data suggest that if an infant with a problem is to be missed by parents using the questionnaire, it is likely to occur at 4 months. Professionals familiar with premature, low birth weight, or sick infants have reported the difficulty of accurate assessment of these infants early in life (Parmelee & Cohen, 1985;Sciarillo, Brown, Robinson, Bennett, & Sells, 1986). Consequently, child-find and screening programs may wish to begin screening after 6 months, or provide systematic follow-up to infants seen at 4 months.…”

Section: Discussionmentioning

confidence: 99%

The Effectiveness of Parental Screening of At-Risk Infants

Bricker¹,

Squires²

1989

Topics in Early Childhood Special Education

View full text Add to dashboard Cite

This study examined the validity, reliability, and cost of a parent-completed screening system called the Infant Monitoring Questionnaires. This system relies on parents to complete developmental questionnaires on their at-risk infants at specific time intervals. The present work replicated and extended a previous study of the questionnaires. The primary analyses included determining (a) the agreement between the infant's classification based on the parent-completed questionnaire and a criterion measure (e.g., Bayley Scales of Infant Development, Stanford-Binet Intelligence Test, Revised Gesell Developmental Schedules); (b) interobserver and test-retest reliability of the questionnaires; and (c) the cost of the questionnaire system. The results indicated that percentage agreement between classifications of infants made using the standardized tests and the questionnaires was high, ranging from 86% to 91%. Under screening rates were low, ranging from zero to 6%; overscreening rates were also low, ranging from 3% to 11%. Interobserver and test-retest agreement were very high. At a cost of about $2.50 per questionnaire, the screening system provides an economical and flexible means of screening at-risk infants while at the same time involving parents in the assessment process.

show abstract

Effectiveness of the Denver Developmental Screening Test with Biologically Vulnerable Infants

Cited by 23 publications

References 0 publications

Developmental milestones of vertically HIV infected and seroreverters children: follow up of 83 children

Developmental milestones of vertically HIV infected and seroreverters children: follow up of 83 children

Neurological profile and neurodevelopment of 88 children infected with HIV and 84 seroreverter children followed from 1995 to 2002

The Effectiveness of Parental Screening of At-Risk Infants

Contact Info

Product

Resources

About